AU2002325783A1 - Vaccine formulation potentiated by the combination of a DNA and an antigen - Google Patents

Vaccine formulation potentiated by the combination of a DNA and an antigen

Info

Publication number: AU2002325783A1
Authority: AU; Australia
Prior art keywords: potentiated; antigen; dna; combination; vaccine formulation
Prior art date: 2001-07-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002325783A

Other versions

AU2002325783B2 (en

Inventor

Nelson Acosta Rivero

Julio C. Alvarez Obregon

Liz Alvarez-Lajonchere Ponce De Leon

Santiago Duenas Carrera

Gillian Martinez Donato

Juan Morales Grillo

Alexis Musacchio Lasa

Rolando Pajon Feyt

Ariel Vina Rodriguez

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centro de Ingenieria Genetica y Biotecnologia CIGB

Original Assignee

Centro de Ingenieria Genetica y Biotecnologia CIGB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-16

Filing date

2002-07-12

Publication date

2003-05-22

2001-07-16 Priority claimed from CU20010171A external-priority patent/CU23244A1/en

2002-07-12 Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB

2003-05-22 Publication of AU2002325783A1 publication Critical patent/AU2002325783A1/en

2006-08-17 Application granted granted Critical

2006-08-17 Publication of AU2002325783B2 publication Critical patent/AU2002325783B2/en

2022-07-12 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CU2001-0171		2001-07-16
CU20010171A CU23244A1 (en)	2001-07-16	2001-07-16	VACCINATION FORMULATION POTENTIATED BY THE COMBINATION OF A DNA WITH AN ANTIGEN
PCT/CU2002/000005 WO2003007986A2 (en)	2001-07-16	2002-07-12	Vaccine formulation potentiated by the combination of a dna and an antigen

Publications (2)

Publication Number	Publication Date
AU2002325783A1 true AU2002325783A1 (en)	2003-05-22
AU2002325783B2 AU2002325783B2 (en)	2006-08-17

Family

ID=40091632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002325783A Ceased AU2002325783B2 (en)	2001-07-16	2002-07-12	Vaccine formulation potentiated by the combination of a DNA and an antigen

Country Status (16)

Country	Link
US (2)	US20040234543A1 (en)
EP (1)	EP1417973B1 (en)
JP (1)	JP4217611B2 (en)
KR (1)	KR100905249B1 (en)
CN (1)	CN1241644C (en)
AR (1)	AR034771A1 (en)
AU (1)	AU2002325783B2 (en)
BR (1)	BR0211181A (en)
CA (1)	CA2453260C (en)
CU (1)	CU23244A1 (en)
ES (1)	ES2393546T3 (en)
MX (1)	MXPA04000431A (en)
MY (1)	MY134885A (en)
RU (1)	RU2294212C2 (en)
WO (1)	WO2003007986A2 (en)
ZA (1)	ZA200400286B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU23496A1 (en) *	2004-09-03	2010-02-23	Ct Ingenieria Genetica Biotech	VACCINE COMPOSITION AGAINST THE VIRUS OF HEPATITIS C
CN101437547A (en) *	2005-01-20	2009-05-20	自然科技公司	Vectors and methods for genetic immunization
EP2152889B1 (en)	2007-05-29	2017-03-15	Nature Technology Corporation	Vectors and methods for genetic immunization
CN104830789A (en) *	2015-05-05	2015-08-12	杨光华	DC cell based on HCV1 antigen, targeting immune cell population, preparation method and applications thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2032381C (en) *	1989-12-18	2006-02-21	Peter E. Highfield	Viral agent
EP0461863A1 (en) *	1990-06-12	1991-12-18	Immuno Japan Inc.	Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus
US7070790B1 (en) *	1993-06-29	2006-07-04	The United States Of America As Represented By The Department Of Health And Human Services	Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US6689757B1 (en) *	1996-02-12	2004-02-10	M.L. Laboratories Plc	Methods for vaccination and vaccines therefor
CU22642A1 (en) *	1996-12-12	2000-12-22	Ct Ingenieria Genetica Biotech	CDNA SEQUENCE DERIVED FROM THE GENE OF THE HEPATITIS C VIRUS AND ITS USE
CN1044092C (en) *	1997-02-26	1999-07-14	上海医科大学	Antigen-antibody-recombination DNA composite type vaccin
FR2760367B1 (en) *	1997-03-06	1999-04-30	Pasteur Merieux Serums Vacc	VACCINE COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEPATITIS C
ATE437951T1 (en) *	1997-05-06	2009-08-15	Novartis Vaccines & Diagnostic	INTRACELLULAR PRODUCTION OF SHORTENED HEPATITIS C-POLYPEPTIDE E2
US6153421A (en) *	1997-07-18	2000-11-28	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Cloned genomes of infectious hepatitis C viruses and uses thereof
GB9726555D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Vaccine
DE19915178A1 (en) *	1999-04-03	2000-10-05	Univ Mainz Johannes Gutenberg	Hepatitis C virus cell culture system
DE60040755D1 (en) *	1999-12-01	2008-12-18	Novartis Vaccines & Diagnostic	RECOGNITION OF ANTIBODIES SPECIFIC TO HEPATITIS C VIRUS (HCV)

2001
- 2001-07-16 CU CU20010171A patent/CU23244A1/en unknown
2002
- 2002-07-10 MY MYPI20022620A patent/MY134885A/en unknown
- 2002-07-12 MX MXPA04000431A patent/MXPA04000431A/en active IP Right Grant
- 2002-07-12 RU RU2004104357A patent/RU2294212C2/en not_active IP Right Cessation
- 2002-07-12 CN CNB028142829A patent/CN1241644C/en not_active Expired - Fee Related
- 2002-07-12 ES ES02760072T patent/ES2393546T3/en not_active Expired - Lifetime
- 2002-07-12 BR BR0211181-0A patent/BR0211181A/en not_active IP Right Cessation
- 2002-07-12 EP EP20020760072 patent/EP1417973B1/en not_active Expired - Lifetime
- 2002-07-12 WO PCT/CU2002/000005 patent/WO2003007986A2/en not_active Ceased
- 2002-07-12 AR ARP020102614 patent/AR034771A1/en not_active Application Discontinuation
- 2002-07-12 AU AU2002325783A patent/AU2002325783B2/en not_active Ceased
- 2002-07-12 JP JP2003513591A patent/JP4217611B2/en not_active Expired - Fee Related
- 2002-07-12 KR KR1020047000574A patent/KR100905249B1/en not_active Expired - Fee Related
- 2002-07-12 CA CA 2453260 patent/CA2453260C/en not_active Expired - Fee Related
- 2002-07-12 US US10/484,112 patent/US20040234543A1/en not_active Abandoned
2004
- 2004-01-14 ZA ZA200400286A patent/ZA200400286B/en unknown
2009
- 2009-04-27 US US12/430,534 patent/US8691234B2/en not_active Expired - Fee Related

Similar Documents

Publication	Publication Date	Title
AU2002336760A1 (en)	2003-06-10	Mutable vaccines
AU2002364081A1 (en)	2003-07-24	Image-rendering device
AU2002327185A1 (en)	2003-07-24	Diagnostic methods and devices
AU2003231352A1 (en)	2003-12-19	Biocidal formulation and methods for the preparation thereof
AU2002326751A1 (en)	2003-03-03	Immunoglobulin e vaccines and methods of use thereof
AU2002361559A1 (en)	2003-04-28	Anticancer vaccine and diganostic methods and reagents
AU2002365228A1 (en)	2003-09-02	Antigen panels and methods of using the same
AU2003267361A1 (en)	2004-04-30	Orthopoxvirus antigens and use thereof
AU2002325783A1 (en)	2003-05-22	Vaccine formulation potentiated by the combination of a DNA and an antigen
AU2002320079A1 (en)	2002-12-23	Vaccines, immunotherapeutics and methods of using the same
AUPR606401A0 (en)	2001-07-26	Pyrazolopyridine compound and pharmaceutical use thereof
AUPR916301A0 (en)	2001-12-20	Pyrazolopyridine compound and pharmaceutical use thereof
AU2002360790A1 (en)	2003-06-17	Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
AUPR548601A0 (en)	2001-06-28	Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001261534A1 (en)	2001-11-20	The meca-79 antigen and related methods
AU2002340850A1 (en)	2003-06-05	Antigen mimotopes and vaccine against cancers
AU2002303093A1 (en)	2002-09-12	Mycobacterial vaccines
AU2002347346A1 (en)	2003-06-17	Dna vaccine
AU2002315309A1 (en)	2002-11-05	Vaccine against tuberculosis
AU2002352638A1 (en)	2003-03-03	Tlp antigen extract, its preparation and diagnostic applications thereof
AU2002314274A1 (en)	2003-05-08	Vaccination against the feline immunodeficiency virus
AU2002362494A1 (en)	2003-04-14	Tumor-peptide antigens from the human prdi-bf1-protein
AU2002258268A1 (en)	2003-06-17	Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
AUPQ865200A0 (en)	2000-08-03	Haemagglutinin antigen
AUPR788601A0 (en)	2001-10-18	Fasciola vaccine